EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies

Michael Hall, Ozichi Amobi, John Khalaf, Afees John Olanrewaju iD, Eileen Brantley iD

International Journal of Molecular Sciences · 03.02.2026 · 27 (3) · 1510

DOI: 10.3390/ijms27031510 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2026. Verfasst von Michael Hall und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA 92354, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Mechanotransduction, Cellular, Extracellular Matrix. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Health Services Resources Administration, Department of Basic Sciences and the Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains a leading cause of mortality among women worldwide. The inherent heterogeneity in tumors among patients with breast cancer poses a challenge to effective therapeutic management. The extracellular matrix (ECM) is an important structural component of the tumor microenvironment (TME) that regulates cellular behavior. When the ECM adopts a stiff configuration, this coincides with biochemical remodeling in response to biomechanical cues that drive tumor cell invasion, immune evasion, and metastatic spread in breast cancer. Emerging studies suggest that patient ancestry significantly impacts ECM stiffness to contribute to disparities in breast cancer survival. In this review, we discuss recent advances in our understanding of how the tumor ECM orchestrates breast cancer invasion and metastasis through mechanotransduction signaling to promote breast cancer progression. We also discuss ancestry-associated differences in breast ECM architecture and agents targeting mechanotransduction signaling pathways with potential to treat breast cancer and improve patient outcomes. Collectively, this review will highlight the significance of tumor mechanobiology and present emerging therapies that target stiffness-sensitive mechanotransduction pathways. By integrating mechanistic insights with therapeutic innovation, we aim to support the development of ECM-targeted therapies to enable more efficacious treatment of aggressive breast cancer subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMechanotransduction, CellularExtracellular MatrixHumansFemaleTumor MicroenvironmentAnimalsEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

breast cancerdisparitiesepithelial-mesenchymal transitionextracellular matrix stiffnessmechanotransductionmetastatic cascadetumor invasion

Autor:innen und Institutionen

  • Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA 92354, USA.
  • Eureka Research Laboratory, Department of Anatomy, Babcock University, Ilishan-Remo 121103, Ogun State, Nigeria.
  • Department of Pharmaceutical Sciences, Loma Linda University Health School of Pharmacy, Loma Linda, CA 92354, USA.
  • Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine, Loma Linda, CA 92354, USA.

ORCID-Profile: Afees John Olanrewaju, Eileen Brantley

Förderung

  • NIGMS NIH HHS
  • Health Services Resources Administration
  • Department of Basic Sciences and the Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine
  • Hispanic Center of Excellence in Pharmacy, Loma Linda University Health School of Pharmacy
  • National Institutes of Health (NIH)/National Institute of General Medical Sciences
  • Union for International Cancer Control

Zitieren

APA

Hall, M., Amobi, O., Khalaf, J., Olanrewaju, A. J., & Brantley, E. (2026). Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies. International Journal of Molecular Sciences, 27(3), 1510. https://doi.org/10.3390/ijms27031510

Vancouver

Hall M, Amobi O, Khalaf J, Olanrewaju AJ, Brantley E. Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies. International Journal of Molecular Sciences. 2026;27(3):1510. doi:10.3390/ijms27031510

BibTeX
@article{Hall2026,
  author = {Hall, Michael and Amobi, Ozichi and Khalaf, John and Olanrewaju, Afees John and Brantley, Eileen},
  title = {Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {3},
  pages = {1510},
  doi = {10.3390/ijms27031510}
}
Kostenlos starten →